J Korean Soc Transplant.  1998 Nov;12(2):191-198.

Clinical Experience of Kidney Transplantation in the Hallym University Hospital

Affiliations
  • 1Department of Surgery, College of Medicine, Hallym University, Korea.
  • 2Department of Internal Medicine, College of Medicine, Hallym University, Korea.
  • 3Department of Urology, College of Medicine, Hallym University, Korea.
  • 4Department of Clinical Pathology, College of Medicine, Hallym University, Korea.
  • 5Department of Pathology, College of Medicine, Hallym University, Korea.
  • 6Department of Transplanation Coordinator, College of Medicine, Hallym University, Korea.

Abstract

Renal transplantation has been adopted as the treatment of choices for most patients with a end stage renal disease. This is the presentation of our experience of renal transplantation at Hallym University Hospital. From March 1984 to July 1998, 207 cases of renal transplantations were performed, 15 cases out of which were lost during follow-up period and excluded from the study. The mean age of recipients was 37.1 years. The male to female ratio was 1.5:1. Eighty nine renal allografts (46.4%) were from living unrelated donors, 59 (30.7%) from living donors and 44 (22.9%) from cadaveric donors. As an immunosuppression theray, a triple regimen was used in 104 cases (54.2), a double regimen in 86 (44.8%) and a single regimen in one (0.5%). The overall rejection developed in 87 cases (45.3%). The rejection rate was 59.3% in renal allografts from living related donors, 37.1% from living unrelated donors and 43.2% from cadavaric donors. The OKT3 and the antilymphocyte globulin (ALG) were used for steroid resistent rejection in 8 and 2 cases, respectively. Post-transplant diabetes mellitus were noticed in 22 cases (11.5). The most common complication was infection (28.1%), and 11 recipeints (5.7%) died during follw-up period. Infection was the leading cause of mortality. The overall graft survival was 92.2% at 1 year span and 83.1% at 3 year span. The overall patient survival was 95.6% at 1 year span and 92.5% at 3 year span.

Keyword

Kidney transplantation clinical results

MeSH Terms

Allografts
Antilymphocyte Serum
Cadaver
Diabetes Mellitus
Female
Follow-Up Studies
Graft Survival
Humans
Immunosuppression
Kidney Failure, Chronic
Kidney Transplantation*
Kidney*
Living Donors
Male
Mortality
Muromonab-CD3
Tissue Donors
Unrelated Donors
Antilymphocyte Serum
Muromonab-CD3
Full Text Links
  • JKSTN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr